Blue Bell Private Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Blue Bell Private Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12	Closed	-$1.48K	–	738
2023 Q4	$1.48K	Hold	12	–	–	﹤0.01%	644
2023 Q3	$1.55K	Hold	12	–	–	﹤0.01%	592
2023 Q2	$1.49K	Hold	12	–	–	﹤0.01%	606
2023 Q1	$1.76K	Hold	12	–	–	﹤0.01%	562
2022 Q4	$1.91K	Hold	12	–	–	﹤0.01%	567
2022 Q3	$2K	Hold	12	–	–	﹤0.01%	601
2022 Q2	$2K	Hold	12	–	–	﹤0.01%	642
2022 Q1	$2K	Hold	12	–	–	﹤0.01%	696
2021 Q4	$2K	Buy	+12	New	+$1.58K	﹤0.01%	686

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Blue Bell Private Wealth Management's JAZZ Position: Q1 2024 in Review

Blue Bell Private Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 12 shares — an estimated $1.48K sold.

Blue Bell Private Wealth Management first reported a position in JAZZ in Q4 2021 and held it in 9 quarters. The position peaked at $2K in Q3 2022. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

Blue Bell Private Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Blue Bell Private Wealth Management sold 12 Jazz Pharmaceuticals shares in Q1 2024, an estimated $1.48K.
Blue Bell Private Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2021 and held it in 9 quarters.
Blue Bell Private Wealth Management's Jazz Pharmaceuticals position peaked at $2K in Q3 2022.
481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Blue Bell Private Wealth Management's 13F filing for Q1 2024, filed 24 Apr 2024.